Search results
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 8 hours ago"The successful development of an intranasal Covid-19 vaccine using this new vector will demonstrate...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 2 days agoThe investigational combination vaccine displayed an acceptable safety and tolerability profile,...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
Morningstar· 1 day agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-< ...
US government to fund up to $500 mln for studies on oral, nasal COVID vaccines
Reuters· 20 hours agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 10 hours agoJust be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about 9% higher...
Moderna says next-gen COVID shot effective in study
BioPharma Dive via Yahoo Finance· 1 day agoTrial data suggest the shot — an important component of an upcoming combination inoculation — has proven at least as effective, and in some cases...
A Combined Flu and COVID-19 Shot May Be Coming
Time via AOL· 4 days agoThe influenza component of the vaccine uses the same mRNA technology behind the existing COVID-19 vaccine but targets ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 4 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Past COVID-19 infection may protect people against some common colds
Euronews via Yahoo News· 1 day ago“Vaccines potentially could be improved if we could replicate some of the immune responses that are...
B.Riley lifts Vaxart shares target on BARDA award By Investing.com
Investing.com· 5 hours agoThe award, which could total up to $453 million, is for conducting a Phase IIb study involving...